Novartis Investigative Site

Monroeville, Pennsylvania 15146

0 studies enrolling now · 3 studies all time

What they study most

Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Relapsing Forms of Multiple Sclerosis

Studies at this site

• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion — Stopped early
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion — Stopped early
• A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis — Completed